DeepHealth

Somerville, MA, United States  All United States companies → — Founded 2015
Imaging AI Specialist
Oncology Radiology
Oncology AI Radiology & Imaging AI
Undisclosed / Acquired (Operating Subsidiary)

Products

Saige-Q
DeepHealth, Inc.
Oncology AI
Saige-Q is an FDA-cleared AI software by DeepHealth that processes mammograms to prioritize suspicious cases for radiologists, enhancing workflow efficiency and supporting early breast cancer detection.
Saige-Density (2.5.0)
DeepHealth, Inc.
Oncology AI
Saige-Density is an FDA-cleared AI software by DeepHealth for automated breast density assessment in mammography, aiding radiologists in consistent and accurate breast tissue categorization.
Saige-Dx
DeepHealth
Oncology AI
AI-powered mammography diagnostic software that assists radiologists in detecting breast cancer earlier and more accurately by identifying suspicious lesions and assigning suspicion levels in mammograms.

See all 3 products →

About DeepHealth

DeepHealth is a global leader in AI-powered health informatics, operating as a wholly-owned subsidiary of RadNet, Inc., a prominent provider of diagnostic imaging in the United States. The company’s core mission is to empower breakthroughs in care through imaging by leveraging advanced AI to enhance operational efficiency, clinical confidence, and the delivery of care. DeepHealth’s solutions are designed to address clinical and operational challenges in complex, high-volume care settings by unifying imaging workflows and enabling earlier disease detection across multiple clinical domains.

DeepHealth’s portfolio includes a cloud-native operating system, DeepHealth OS, which unifies data across clinical and operational workflows and provides personalized AI-powered workspaces for radiologists and other imaging stakeholders. Their offerings include AI-powered mammography interpretation software like Saige-Density for breast density assessment, Saige-Q for productivity, triage, and prioritization, and Saige-Dx for diagnostic breast cancer screening. The company also offers solutions for lung, prostate, brain, chest, neuro, thyroid, and musculoskeletal health, encompassing detection, assessment, monitoring, interpretation, and follow-up workflows across various modalities such as MR, CT, X-ray, mammography, and ultrasound. DeepHealth aims to integrate clinical AI, informatics, and workflows to create an end-to-end approach that connects patient engagement, scheduling, image acquisition, interpretation, reporting, and clinical collaboration.

Focus Areas

AI-powered health informatics radiology AI machine learning deep learning breast cancer screening prostate cancer detection thoracic nodule detection neurodegenerative changes assessment thyroid ultrasound imaging enterprise imaging population health workflow optimization

Business Intelligence

TechnologyDeepHealth OS (cloud-native operating system), cloud-native or hybrid platform, AI operating system

What Physicians Need to Know

Specializations
DeepHealth specializes in AI-powered health informatics, radiology AI, machine learning, and deep learning. Their solutions cover breast cancer screening, prostate cancer detection, thoracic nodule detection, neurodegenerative changes assessment, and thyroid ultrasound imaging.
Key Differentiators
DeepHealth offers a comprehensive, cloud-native, AI-infused informatics portfolio that orchestrates diagnostic workflows. Their DeepHealth OS is a cloud-native workflow engine that integrates data across an enterprise with API-based modules and offers personalized workflow applications. They provide a unified diagnostic workspace with PACS functionality, an enhanced viewer, advanced image management, and smart interpretation capabilities. DeepHealth also focuses on population health with end-to-end AI-powered solutions for large-scale diagnostic and screening programs.
Technology Stack
DeepHealth leverages a cloud-native operating system and a microservice architecture. They utilize Ketryx for connected lifecycle management, accelerating product development and ensuring quality and compliance, especially for FDA-regulated software and AI/ML-based applications. Their Diagnostic Suite features a cloud-first interpretation and reporting solution with ultra-fast viewing, advanced visualization, structured reporting, and intelligent worklist management. It also offers native clinical AI orchestration, providing access to over 140 AI algorithms from 75 vendors and DeepHealth's own clinical AI applications.
Impact on Patient Care
DeepHealth aims to enable earlier and more efficient cancer detection and empower clinicians with information for more accurate diagnoses. Studies have shown their AI can bring specialist-level breast cancer detection to more patients, with general radiologists achieving comparable cancer detection rates to breast imaging specialists. Their solutions enhance diagnostic accuracy and streamline workflows, leading to improved patient outcomes.
Physician Tip

For physicians, DeepHealth's solutions offer a unified diagnostic workspace that integrates PACS functionality, an enhanced viewer, and smart interpretation capabilities, streamlining diagnostic workflows. The AI-powered clinical insights and automation embedded in DeepHealth OS can personalize workflow applications for radiologists, technologists, and referring physicians. The platform provides access to a vast array of AI algorithms, orchestrated natively within the worklist, reporting, viewer, and workflow engine, eliminating the need for separate marketplaces or integrations. This can lead to improved diagnostic accuracy, reduced reporting times, and enhanced efficiency in managing patient care. DeepHealth's solutions also support large-scale screening programs by enhancing accuracy and optimizing radiologists' expertise.

DeepHealth OS is designed as a cloud-native workflow engine that integrates data across an enterprise using API-based modules. Their Diagnostic Suite is an end-to-end solution that can function as a standalone system or interoperate with legacy PACS systems. DeepHealth's platform also offers native clinical AI orchestration, providing access to over 140 AI algorithms from 75 vendors, integrated directly into the worklist, reporting, viewer, and workflow engine without requiring separate marketplaces or point solutions. They also integrate with HIS/EMR systems to simplify staff processes.

Products by DeepHealth

3 products in the directory

Saige-Q
DeepHealth, Inc.
Oncology AI
Saige-Q is an FDA-cleared AI software by DeepHealth that processes mammograms to prioritize suspicious cases for radiologists, enhancing workflow efficiency and supporting early breast cancer detection.
Saige-Density (2.5.0)
DeepHealth, Inc.
Oncology AI
Saige-Density is an FDA-cleared AI software by DeepHealth for automated breast density assessment in mammography, aiding radiologists in consistent and accurate breast tissue categorization.
Saige-Dx
DeepHealth
Oncology AI
AI-powered mammography diagnostic software that assists radiologists in detecting breast cancer earlier and more accurately by identifying suspicious lesions and assigning suspicion levels in mammograms.

What the Web Says

DeepHealth is a company that develops machine learning software to assist doctors, primarily focusing on screening mammography and breast ultrasound. They aim to enhance workflow, improve accuracy, and increase efficiency in medical imaging. While there are positive sentiments regarding their product's impact on patient outcomes and radiologist efficiency, some employer reviews suggest a lack of opportunities for quick advancement and innovation within the company.

Overall: Mixed

Strengths

  • AI tools enhance workflow and improve accuracy in breast cancer detection.
  • Products can reduce radiologist interpretation times.
  • Employees feel part of a caring community focused on excellent patient outcomes.
  • Award-winning algorithms in screening mammography.
  • Collaboration with top hospitals.
  • FDA clearance for AI tools.

Limitations

  • Lacking opportunities for quick advancement or innovation for employees.
  • Compensation and benefits for knowledge workers may not be competitive with other large corporations.
  • Work may not always align with an intern's specific interests or competencies.
  • Limited public clinician sentiment available on platforms like Reddit.
  • G2 and Capterra show no user reviews for DeepHealth's product.

Based on reviews from: Handshake, Indeed.com, MedTech Dive, FeaturedCustomers, iCAD (now part of DeepHealth), Reddit

Last updated: 2026-10-21

Videos

News, demos, and interviews about DeepHealth.

Loading videos...

Videos load interactively. If none appear, search YouTube for DeepHealth →

View all on YouTube

Press & Coverage

DeepHealth
DeepHealth Achieves Multiple Regulatory Milestones for Neuro, Prostate and LumbarMR
DeepHealth received CE Marking for its Neuro Suite (Brain Health and Brain Age solutions), LumbarMR solution, and FDA 510(k) clearance and CE Marking for its Prostate AI solution, expanding its portfolio of clinical AI solutions in radiology.
2026-05
DeepHealth
DeepHealth Receives FDA Clearance for Next-Generation Chest XRay AI Solution Built on a Proprietary Foundation Model
DeepHealth announced FDA 510(k) clearance for its Chest XRay AI solution, one of the first FDA-cleared chest X-ray computer-aided detection solutions built on a foundation model.
2026-09
MedTech Dive
DeepHealth gets FDA nod for AI tool that reads ultrasounds, creates reports
DeepHealth received FDA 510(k) clearance for an AI tool that detects and characterizes lesions from breast ultrasounds and generates reports, aiming to save radiologists time and improve breast cancer detection.
2026-08
GlobeNewswire
DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound
DeepHealth announced FDA 510(k) clearance for its AI-powered Breast Ultrasound solution, which automates lesion detection, characterization, and reporting to enhance standardization, accuracy, and efficiency in breast ultrasound imaging.
2026-07
Signalbase
DeepHealth Raises $103M in Funding to Revolutionize Healthcare Innovation
DeepHealth, a Hong Kong-based company specializing in AI-powered health informatics, secured $103 million in its latest funding round to accelerate R&D, expand its AI platforms for early disease detection, and fuel market expansion.
2025-04
RadNet Inc
DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting
DeepHealth launched Reporting Pro, an AI-powered solution designed to transform radiology reporting by integrating speech recognition, AI-generated clinical findings, measurements, impressions, quality assurance, and structured reporting into a single workflow.
2026-06
DeepHealth
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
DeepHealth received FDA 510(k) clearances for two new Breast Suite functionalities: Breast Arterial Calcification (BAC) Assessment and prior exam integration into ProFound Pro (Mammo Dx), aiming to improve cancer detection and provide cardiovascular insights.
2026-06
DeepHealth
Study Shows AI Can Bring Specialist-Level Breast Cancer Detection to More Patients
A study published in Radiology demonstrated that general radiologists achieved breast cancer detection rates comparable to breast imaging specialists when integrating DeepHealth's AI-powered workflow.
2026-04

Frequently Asked Questions

DeepHealth provides AI solutions for breast cancer screening, prostate cancer detection, thoracic nodule detection, and neurodegenerative changes assessment. These solutions are designed to integrate seamlessly with existing PACS and VNA systems, leveraging industry standards to optimize workflow and enhance diagnostic accuracy for radiologists and healthcare administrators.
DeepHealth rigorously validates its machine learning and deep learning models using large, diverse datasets and collaborates with leading medical institutions. Our validation process includes retrospective and prospective studies, peer-reviewed publications, and continuous monitoring to ensure high accuracy and reliability in real-world clinical settings.
DeepHealth prioritizes data privacy and security through robust encryption, access controls, and anonymization techniques. Our products are designed to be fully compliant with HIPAA, GDPR, and other relevant healthcare regulations, undergoing regular security audits and assessments to protect sensitive patient information.
DeepHealth offers flexible pricing models tailored to the specific needs and scale of healthcare organizations, which can include subscription-based or per-study fees. We provide comprehensive support, including initial implementation, ongoing technical assistance, and extensive training for clinical staff and IT teams to ensure successful adoption and utilization of our platforms.
DeepHealth's long-term vision includes expanding our AI applications to further enhance population health management and workflow optimization across various medical specialties, including thyroid ultrasound imaging. We are committed to continuous innovation and strategic partnerships to ensure our solutions evolve with the needs of the healthcare industry. DeepHealth is backed by strong investment and a clear growth strategy, ensuring company stability and sustained product development.

Investors

Who's funded DeepHealth.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.